logo

For the Inventor, By the Inventor

Berlin, Germany

Jorg Kroll

This inventor holds 8 USPTO granted patents. Top assignees: Schering Aktiengesellschaft, Bayer Schering Pharma Ag. Active years: 2001-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jorg Kroll. Retrieved from https://idiyas.com/inventor/jorg-kroll

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 37.5

Average Co-Inventor Count = 8.3

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:

goldMedal7 out of 1,409 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 192 
 
Bayer Schering Pharma Ag
 patents

Years Active: 2001-2009

Loading Chart...
8 patents (USPTO):Explore Patents
1. 7538100 - 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations (2009-05-26),
2. 7145015 - Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents (2006-12-05),
3. 7018994 - 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, USE OF THE 17α-ALKYL-17β-OXY-ESTRATRIENES FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS AS WELL AS PHARMACEUTICAL PREPARATIONS (2006-03-28),
4. 6878750 - Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents (2005-04-12),
5. 6790842 - 11&bgr; LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11&bgr; LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS (2004-09-14),
6. 6780855 - 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11&bgr;-HALOGEN-7&agr;-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS (2004-08-24),
7. 6495607 - Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents (2002-12-17),
8. 6288051 - 7 &agr;-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 &agr;(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents (2001-09-11),

Title: Jorg Kroll: A Pioneer in Sustainable Technology and Pharmaceutical Innovation

Introduction:

Jorg Kroll, a dedicated inventor based in Berlin, DE, has continuously pushed the boundaries of technology to create a more sustainable future. His passion for innovation has made him a true trailblazer in the world of inventions.

Latest Patents:

Kroll's latest patents include the groundbreaking inventions of 17α-alkyl-17β-oxy-estratrienes and intermediate products for their production. These compounds have antiestrogenic action and are essential in the production of pharmaceutical agents and preparations. Additionally, his patents cover Benzocycloheptenes, which exhibit selective estrogenic activity on bones and are used in the production of pharmaceutical agents for the prophylaxis and therapy of osteoporosis.

Career Highlights:

Throughout his career, Jorg Kroll has accumulated a total of 8 patents, showcasing his innovative spirit and commitment to driving technological advancements. He has made significant contributions to companies such as Schering Aktiengesellschaft and Bayer Schering Pharma AG, where his expertise has been instrumental in developing cutting-edge pharmaceutical solutions.

Collaborations:

Working alongside accomplished individuals like Rolf Bohlmann and Rosemarie Lichtner, Kroll has fostered a collaborative environment that thrives on creativity and ingenuity. These partnerships have played a crucial role in the success of his inventions and have propelled him to the forefront of the industry.

Conclusion:

In conclusion, Jorg Kroll stands as a beacon of innovation, with his relentless pursuit of sustainable technology and pharmaceutical advancements shaping the future of inventions. His remarkable dedication to excellence and his pioneering spirit make him a true luminary in the world of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…